V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330002632 | 330001444 | 1.68 | 72.9 | Adjuvant (A) | null | 2017-10-03 | Cisplatin + Doxorubicin | N | N | 330010717 | CISPLATIN + DOXORUBICIN |
| 330002633 | 330001444 | 1.7 | null | Adjuvant (A) | null | 2017-04-17 | Cisplatin + Doxorubicin | null | null | 330010717 | CISPLATIN + DOXORUBICIN |
| 330002634 | 330001444 | 1.8 | 101.9 | Curative (C) | 2016-07-25 | 2016-08-15 | Carboplatin + Etoposide iv&po | 02 | N | 330010717 | CARBOPLATIN + ETOPOSIDE |
| 330002635 | 330001444 | 0 | 78.6 | Curative (C) | 2017-03-04 | 2017-03-04 | BENDAMUSTINE + RITUXIMAB | N | N | 330010717 | BENDAMUSTINE + RITUXIMAB |
| 330002636 | 330001444 | null | 83 | Disease modification (D) | 2015-04-08 | 2015-04-23 | BENDAMUSTINE + RITUXIMAB | null | N | 330010717 | BENDAMUSTINE + RITUXIMAB |
| 330002637 | 330001445 | 1.67 | 101.6 | Curative (C) | null | 2018-05-18 | Bendamustine+Rituximab (1st Course) | null | null | 330010745 | BENDAMUSTINE + RITUXIMAB |
| 330002638 | 330001446 | 1.57 | 47.3 | Curative (C) | 2016-08-19 | 2016-08-24 | Cisplatin + Doxorubicin | 02 | N | 330010747 | CISPLATIN + DOXORUBICIN |
| 330002639 | 330006762 | 1.7 | 56.5 | Neo-adjuvant (N) | 2017-06-11 | 2017-06-11 | Cisplatin + Doxorubicin | 2 | N | 330010755 | CISPLATIN + DOXORUBICIN |
| 330002640 | 330001447 | 1.74 | 86 | null | 2015-11-21 | 2015-11-21 | Carboplatin AUC 2 - 5 | 2 | null | 330010757 | CARBOPLATIN |
| 330002641 | 330006763 | 1.83 | 79.8 | Not known (9) | 2015-08-03 | 2015-08-08 | Bendamustine+Rituximab (1st Course) | null | null | 330010763 | BENDAMUSTINE + RITUXIMAB |
| 330002642 | 330006763 | 1.84 | 89.5 | Adjuvant (A) | 2016-07-26 | 2016-08-17 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 330010763 | CARBOPLATIN + PACLITAXEL |
| 330002643 | 330006763 | 1.67 | 63.5 | Neo-adjuvant (N) | 2015-01-02 | 2015-01-13 | Carboplatin + Paclitaxel (3 weekly) | N | N | 330010763 | CARBOPLATIN + PACLITAXEL |
| 330002644 | 330006763 | 1.8 | 96 | Curative (C) | null | 2017-05-30 | Cisplatin + Doxorubicin | null | null | 330010763 | CISPLATIN + DOXORUBICIN |
| 330002645 | 330001448 | 1.63 | 73.15 | Palliative (P) | null | 2016-11-02 | Cisplatin + Doxorubicin | null | null | 330010772 | CISPLATIN + DOXORUBICIN |
| 330002652 | 330001450 | 1.68 | 72.2 | Curative (C) | 2013-07-20 | 2013-07-21 | Carboplatin AUC 2 - 5 | N | N | 330010803 | CARBOPLATIN |
| 330002653 | 330006766 | null | 75 | Palliative (P) | 2014-10-06 | 2014-12-19 | Carboplatin AUC 2 - 5 | N | N | 330010807 | CARBOPLATIN |
| 330002654 | 330001451 | 1.43 | 65.8 | Curative (C) | null | 2015-03-08 | CARBOPLATIN | null | null | 330010826 | CARBOPLATIN |
| 330002655 | 330001452 | 1.72 | null | Palliative (P) | 2016-08-29 | 2016-10-15 | DOXORUBICIN | 02 | N | 330010831 | DOXORUBICIN |
| 330002656 | 330001453 | null | 52 | Curative (C) | 2017-05-31 | 2017-05-31 | CARBOPLATIN + ETOPOSIDE | 02 | N | 330010836 | CARBOPLATIN + ETOPOSIDE |
| 330002657 | 330001454 | 1.74 | 104.3 | Curative (C) | 2014-08-10 | 2015-04-29 | Rituximab | N | N | 330010839 | RITUXIMAB |
| 330002658 | 330001454 | 1.53 | 98 | Palliative (P) | 2016-06-17 | 2016-07-12 | LIPOSOMAL DOXORUBICIN | N | N | 330010839 | LIPOSOMAL DOXORUBICIN |
| 330002659 | 330001454 | 1.61 | 91.4 | Adjuvant (A) | 2014-07-08 | 2014-07-17 | CARBOPLATIN | N | N | 330010839 | CARBOPLATIN |
| 330002660 | 330001455 | 1.8 | 71.8 | Neo-adjuvant (N) | 2017-12-22 | 2018-01-05 | Cisplatin + Doxorubicin | N | N | 330010845 | CISPLATIN + DOXORUBICIN |
| 330002661 | 330006768 | 1.77 | 51 | Neo-adjuvant (N) | 2013-07-02 | 2013-07-16 | Cisplatin + Doxorubicin | N | N | 330010854 | CISPLATIN + DOXORUBICIN |
| 330002662 | 330001456 | 1.6 | 85.8 | Disease modification (D) | 2017-12-12 | 2018-01-08 | BENDAMUSTINE + RITUXIMAB | N | N | 330010860 | BENDAMUSTINE + RITUXIMAB |
| 330002664 | 330001458 | 0 | 91 | Curative (C) | 2015-12-09 | 2015-12-23 | CARBOPLATIN + ETOPOSIDE | N | N | 330010873 | CARBOPLATIN + ETOPOSIDE |
| 330002665 | 330006769 | 1.73 | 95 | Curative (C) | 2018-01-24 | 2018-01-24 | Liposomal Doxorubicin (20mg/m2) | N | N | 330010880 | LIPOSOMAL DOXORUBICIN |
| 330002666 | 330006769 | 1.77 | null | Palliative (P) | null | 2015-07-01 | Carboplatin + Etoposide IV 3 day | null | null | 330010880 | CARBOPLATIN + ETOPOSIDE |
| 330002667 | 330006769 | 1.62 | null | Curative (C) | 2016-05-10 | 2016-05-12 | Carboplatin AUC 2 - 5 | 02 | N | 330010880 | CARBOPLATIN |
| 330002668 | 330001459 | 1.57 | 68.1 | null | 2015-09-01 | 2015-09-02 | Rituximab | N | N | 330010886 | RITUXIMAB |
| 330002669 | 330001459 | 1.63 | 56 | Adjuvant (A) | 2016-06-30 | 2016-06-30 | Bendamustine+Rituximab (1st Course) | N | N | 330010886 | BENDAMUSTINE + RITUXIMAB |
| 330002670 | 330001460 | 1.73 | 0 | Curative (C) | null | 2016-01-02 | Carboplatin AUC 6 - 10 | N | N | 330010902 | CARBOPLATIN |
| 330002671 | 330001460 | 1.84 | null | null | 2017-02-22 | 2017-03-07 | Cisplatin + Doxorubicin | N | N | 330010902 | CISPLATIN + DOXORUBICIN |
| 330002674 | 330001462 | 1.6 | 5.6 | Disease modification (D) | null | 2018-06-28 | Liposomal Doxorubicin (Caelyx) | N | N | 330010910 | LIPOSOMAL DOXORUBICIN |
| 330002675 | 330006773 | 1.43 | null | Curative (C) | 2015-08-21 | 2015-08-21 | BENDAMUSTINE + RITUXIMAB | N | N | 330010911 | BENDAMUSTINE + RITUXIMAB |
| 330002676 | 330006773 | 1.83 | 83.6 | Curative (C) | 2017-05-18 | 2017-06-01 | Liposomal Doxorubicin (Caelyx) | N | N | 330010911 | LIPOSOMAL DOXORUBICIN |
| 330002679 | 330001464 | 1.76 | 76 | null | 2013-02-24 | 2013-02-24 | Carboplatin + Paclitaxel (3 weekly) | 02 | Y | 330010934 | CARBOPLATIN + PACLITAXEL |
| 330002684 | 330001466 | 1.8 | 69 | null | 2013-07-28 | 2013-08-07 | Rituximab | 02 | N | 330010959 | RITUXIMAB |
| 330002689 | 330001468 | 1.57 | 80.5 | Neo-adjuvant (N) | 2016-06-22 | 2016-07-14 | CARBOPLATIN + PACLITAXEL | 02 | N | 330010974 | CARBOPLATIN + PACLITAXEL |
| 330002694 | 330001470 | 1.65 | 58.4 | Not known (9) | 2017-03-28 | 2017-04-14 | Carboplatin AUC 6 - 10 | N | N | 330010997 | CARBOPLATIN |
| 330002695 | 330001470 | 1.88 | 100 | Neo-adjuvant (N) | 2017-08-08 | 2017-08-14 | Cisplatin + Doxorubicin | N | N | 330010997 | CISPLATIN + DOXORUBICIN |
| 330002696 | 330001471 | 1.46 | 71 | null | 2015-11-08 | 2015-11-16 | Rituximab | null | null | 330011008 | RITUXIMAB |
| 330002697 | 330001471 | 1.78 | null | Palliative (P) | 2016-04-06 | 2016-04-11 | BENDAMUSTINE + RITUXIMAB | N | N | 330011008 | BENDAMUSTINE + RITUXIMAB |
| 330002698 | 330009663 | 1.6 | 80.74 | Palliative (P) | 2016-09-03 | 2016-09-30 | BENDAMUSTINE + RITUXIMAB | null | N | 330011013 | BENDAMUSTINE + RITUXIMAB |
| 330002699 | 330001472 | null | 81.55 | Palliative (P) | 2013-07-02 | 2013-07-09 | Liposomal Doxorubicin (Caelyx) | N | N | 330011027 | LIPOSOMAL DOXORUBICIN |
| 330002700 | 330001473 | 1.76 | 78.6 | Palliative (P) | 2013-05-28 | 2013-06-15 | Cisplatin + Doxorubicin | N | N | 330011029 | CISPLATIN + DOXORUBICIN |
| 330002701 | 330001473 | 1.78 | 78 | Adjuvant (A) | 2015-03-24 | 2015-03-31 | Carboplatin + Paclitaxel (3 weekly) | 2 | N | 330011029 | CARBOPLATIN + PACLITAXEL |
| 330002702 | 330001474 | 1.63 | 63.5 | Curative (C) | 2014-06-15 | 2014-06-22 | Cisplatin + Doxorubicin | N | N | 330011042 | CISPLATIN + DOXORUBICIN |
| 330002703 | 330006781 | 1.7 | 71.9 | null | 2015-01-28 | 2015-02-17 | Cisplatin + Doxorubicin | 02 | Y | 330011043 | CISPLATIN + DOXORUBICIN |
| 330002704 | 330006781 | null | 48.3 | Disease modification (D) | 2017-06-09 | 2017-06-10 | BENDAMUSTINE + RITUXIMAB | null | N | 330011043 | BENDAMUSTINE + RITUXIMAB |